Clinical Trial Update: Photodynamic Therapy of Primary Localized Prostate Cancer With the SpectraCure P18 System [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 clinical study evaluating photodynamic therapy for primary localized prostate cancer using the SpectraCure P18 System is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• SpectraCure P18 System

Snippet

Sponsor: SpectraCure AB | Conditions: Prostate Cancer | Phase 1, Phase 2 | Status: RECRUITING